Guardant Health GH Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 256%+16.2pp | 252.4%+15.1pp | 248.7%+12.5pp | 244.1%— | 239.7%— | |
| Operating margin | -190.6%+82.1pp | -207.9%+93.8pp | -223.4%+118pp | -248.8%+114pp | -272.6%+118pp | |
| Net margin | -176.6%+86.5pp | -190.3%+95.3pp | -207%+105pp | -236.8%+81.5pp | -263.1%+78.6pp | |
| EBITDA margin | -173.5%+75.1pp | -189%+86.9pp | -202.8%+111pp | -226.5%+107pp | -248.6%+111pp | |
| Free cash flow margin | -107.5%+55.2pp | -125%+48.2pp | -138.4%+58.8pp | -149%+76.4pp | -162.7%+91.3pp | |
| Returns | ||||||
| Return on assets | -106.8%+6.3pp | -107.6%+6.9pp | -110.5%+5.6pp | -112.9%-2.8pp | -113.2%-4.0pp | |
| Efficiency | ||||||
| Asset turnover | 2.4×+0.7× | 2.3×+0.7× | 2.2×+0.7× | 1.9×+0.6× | 1.7×+0.5× | |
| Inventory turnover | 17.3×+1.1× | 16.8×+0.6× | 16.7×+0.9× | 16.3×— | 16.2×— | |
| Liquidity | ||||||
| Current ratio | 16.7×-4.7× | 16.2×-7.1× | 16×-9.1× | 18.7×-6.1× | 21.4×-4.0× | |
| Quick ratio | 15.4×-4.6× | 14.8×-7.1× | 14.6×-9.2× | 17.3×-6.2× | 20×-4.1× | |
| Cash ratio | 11.4×-3.6× | 11.2×-5.4× | 12.3×-6.9× | 12.9×-4.9× | 15×+1.0× | |
| Leverage | ||||||
| Debt-to-assets | 3.8×+1.7× | 3.9×+2.6× | 3.9×+3.4× | 3×+2.5× | 2.1×+1.6× | |
| Interest coverage | -494.6×+242× | -560.9×+214× | -620.6×+202× | -688.6×+134× | -736.6×+98.6× | |
| Per Share | ||||||
| Book value per share | -$7.47-104% | -$8.12-653% | -$8.46-673% | -$6.11-257% | -$3.66-155% | |
| Valuation | ||||||
| Market capitalization | $39.37B+156% | $32.51B+157% | $23.02B+89.4% | $18.05B+40.8% | $15.39B+14.2% | |
| Enterprise value | $42.43B+178% | $35.47B+220% | $25.46B+183% | $19.36B+95.6% | $15.27B+34.6% | |
| Price / sales | 40.8×+19.4× | 36.4×+17.6× | 28×+8.5× | 23.4×+1.5× | 21.5×-3.2× | |
| EV / sales | 44.1×+23.0× | 39.7×+23.5× | 31×+16.7× | 25.1×+8.0× | 21.1×+0.1× | |
| Free cash flow yield | -11.5%+19.8pp | -15.3%+22.1pp | -20.8%+19.9pp | -27.2%+14.2pp | -31.3%+10.8pp | |
| Earnings yield | -18.5%+33.0pp | -22.9%+39.1pp | -31.3%+33.7pp | -44.3%+14.9pp | -51.5%+5.9pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Guardant Health's profit margins?
- Guardant Health (GH) runs a 64.9% gross margin and a -41.4% operating margin, with a -40.1% net margin.
- Where do Guardant Health's ratios come from?
- Every ratio is computed from Guardant Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
